Publications found:
47,216
Sort by:
2019-2023 Diagnostic Imaging: A Market in Transition--X-ray, Ultrasound, MRI, CT, Nuclear Medicine, PET, PACS
US$ 3,850.00
This new worldwide strategic overview of the diagnostic imaging market includes the following:- Estimates of the market size and growth.- Sales forecasts by ... etc.- System service and support.- Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, ...
January 2019
185 pages
Molecular Diagnostics: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousand by the following Applications: Infectious Disease Testing, Blood Screening, ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
December 2018
570 pages
2019-2023 Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 19,700.00
... Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review ... test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...
December 2018
630 pages
2019-2023 US Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Opportunities for Suppliers
US$ 9,700.00
... potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist ... , Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect ...
December 2018
465 pages
In Vitro Diagnostics (IVD) Market by Product Type (Reagents, Instruments, and Software & Services), Technique (Immunodiagnostics {Enzyme-Linked Immunosorbent Assay [Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FIA), and Colorimetric Immunoassay (CI)], Rapid Tests, Enzyme-Linked ImmunoSpot (ELISPOT), Radioimmunoassay (RIA), and Western Blot}, Hematology, Molecular Diagnostics {Polymerize Chain Reaction (PCR), Isothermal Nucleic Acid Technology (INAAT), Hybridization, DNA Diagnostics, Microarray, and Others}, Tissue Diagnostics, Clinical Chemistry {Basic Metabolic Panel, Liver Panel, Lipid Profile, Thyroid Function Panel, Electrolyte Panel, and Specialty Chemicals}, and Other IVD Techniques), Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and End User (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care Testing, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
US$ 5,370.00
IVD Market Overview: The global in vitro diagnostics (IVD) market was valued at $64,479 million in 2017, and is ... estimated to reach at $93,614 million by 2025, registering a CAGR of 4.8% from 2018 to 2025. In vitro diagnostic (IVD) ...
December 2018
377 pages
